Biocure Technology Inc.
Biocure is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting clinical trials of its biosimilar candidates of Interferon Beta 1b, Filgrastim and Ranibizumab.
Biocure Technology Inc. (CURE)
le 28 novembre/November 2017
Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.
Listing and disclosure documents will be available at thecse.com on the trading date.